Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Mar:90 Suppl 1:3-5.
doi: 10.1016/S0365-6691(15)30002-2.

[Role of VEGF in diseases of the retina]

[Article in Spanish]
Affiliations
Review

[Role of VEGF in diseases of the retina]

[Article in Spanish]
Luis Arias Barquet. Arch Soc Esp Oftalmol. 2015 Mar.

Abstract

Angiogenesis is the process through which new blood vessels are formed, based on preexisting vessels, and is the paradigm of diseases such as cancer and exudative ageassociated macular degeneration (ARMD). Several proangiogenic factors have been identified, such as vascular endothelial growth factor (VEGF), especially VEGF-A, which activates endothelial cells and promotes cell proliferation, migration, and an increase in vascular permeability. VEGF is also involved in the etiopathogenesis of other retinal diseases, such as diabetic macular edema and macular edema secondary to retinal vein occlusion. Likewise, there is increasing evidence that placental growth factor (PIGF) acts recepsynergetically with VEGF in promoting these diseases. Currently, the main treatment for these diseases are the anti-VEGF drugs, aflibercept, ranibizumab and bevacizumab. These agents differ in their molecular structure and mechanism of action.

Keywords: Angiogenesis; Angiogénesis; Degeneración macular asociada a la edad exudativa; Diabetic macular edema; Edema macular diabético; Edema macular secundario a oclusiones venosas retinianas; Exudative age-related macular degeneration (ARMD); Factor de crecimiento del endotelio vascular; Factor de crecimiento placentario; Placental Growth Factor (PIGF); Terapia antifactor de crecimiento del endotelio vascular; Vascular Endothelial Growth Factor (VEGF).

PubMed Disclaimer

MeSH terms

LinkOut - more resources